PLP (178-191) is a key encephalitogenic epitope in SJL mice, inducing earlier disease onset than the PLP (139-151) epitope while yielding comparable disease incidence and pathology. This peptide is a critical tool for studying experimental autoimmune encephalomyelitis (EAE) in vivo, facilitating research into multiple sclerosis mechanisms and immunomodulatory therapies.